Sarah Paisdzior, Annette Grüters, Harald Jüppner, Mehul Dattani, Thomas J Gardella, Michael Mannstadt, Heiko Krude, Jeremy Allgrove, John W Gregory, Heike Biebermann, Monica Reyes, Patrick Scheerer, Sarah Kiff, Ian Tully, Louise C Wilson, Detlef Bockenhauer, Dirk Schnabel, Gunnar Kleinau
Journal: The Journal of clinical endocrinology and metabolism 2020;104(4):1079-1089
PMID: 30312418
CONTEXT
The α subunit of the stimulatory G protein (Gαs) links numerous receptors to adenylyl cyclase. Gαs, encoded by GNAS, is expressed predominantly from the maternal allele in certain tissues. Thus, maternal heterozygous loss-of-function mutations cause hormonal resistance, as in pseudohypoparathyroidism type Ia, whereas somatic gain-of-function mutations cause hormone-independent endocrine stimulation, as in McCune-Albright syndrome.
OBJECTIVE
We report two unrelated boys presenting with a new combination of clinical findings that suggest both gain and loss of Gαs function.
DESIGN AND SETTING
Clinical features were studied and sequencing of GNAS was performed. Signaling capacities of wild-type and mutant Gαs were determined in the presence of different G protein-coupled receptors (GPCRs) under basal and agonist-stimulated conditions.
RESULTS
Both unrelated patients presented with unexplained hyponatremia in infancy, followed by severe early onset gonadotrophin-independent precocious puberty and skeletal abnormalities. An identical heterozygous de novo variant (c.1136T>G; p.F376V) was found on the maternal GNAS allele in both patients; this resulted in a clinical phenotype that differed from known Gαs-related diseases and suggested gain of function at the vasopressin 2 receptor (V2R) and lutropin/choriogonadotropin receptor (LHCGR), yet increased serum PTH concentrations indicative of impaired proximal tubular PTH1 receptor (PTH1R) function. In vitro studies demonstrated that Gαs-F376V enhanced ligand-independent signaling at the PTH1R, LHCGR, and V2R and, at the same time, blunted ligand-dependent responses. Structural homology modeling suggested mutation-induced modifications at the C-terminal α5 helix of Gαs that are relevant for interaction with GPCRs and signal transduction.
CONCLUSIONS
The Gαs p.F376V mutation causes a previously unrecognized multisystem disorder.
Copyright © 2019 Endocrine Society.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.